Involvement of inducible nitric oxide synthase in inflammation-induced dopaminergic neurodegeneration

Neuroscience

Volumn 110, Issue 1, 2002, Pages 49-58

  Iravani, M M ^a   Kashefi, K ^a   Mander, P ^a   Rose, S ^a   Jenner, P ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Dopaminergic neurones; Inducible nitric oxide synthase; Inflammation; Lipopolysaccharide; Parkinson's disease

Indexed keywords

3 NITROTYROSINE; FLUOROGOLD; GLIAL FIBRILLARY ACIDIC PROTEIN; ISOENZYME; LIPOPOLYSACCHARIDE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE DEHYDROGENASE; S METHYLPSEUDOTHIOUREA; THIOUREA DERIVATIVE; TYROSINE 3 MONOOXYGENASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTOSIS; CELL COUNT; CELL DEATH; CELL LABELING; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; DOSE RESPONSE; ENCEPHALITIS; ENZYME REGULATION; IMMUNOREACTIVITY; MACROPHAGE; MALE; MESENCEPHALON; NERVE DEGENERATION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SUBSTANTIA NIGRA; VENTRAL TEGMENTUM;

ANIMALS; CELL COUNT; CELL DEATH; DOPAMINE; ENCEPHALITIS; FLUORESCENT DYES; GLIAL FIBRILLARY ACIDIC PROTEIN; HYDROXYL RADICAL; LIPOPOLYSACCHARIDES; MACROPHAGES; MALE; NADPH DEHYDROGENASE; NEURONS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OXIDATIVE STRESS; PARKINSON DISEASE; PEROXYNITROUS ACID; RATS; RATS, WISTAR; SUBSTANTIA NIGRA; TYROSINE 3-MONOOXYGENASE;

EID: 0036499736     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(01)00562-0     Document Type: Article

References (52)

1. Major histocompatibility complex antigen expression on rat microglia following epidural kainic acid lesions
2. The CNS acute inflammatory response to excitotoxic neuronal cell death
3. Inactivation of tyrosine hydroxylase by nitration following exposure to peroxynitrite and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)
4. Apparent hydroxyl radical production by peroxynitrite: Implications for endothelial injury from nitric oxide and superoxide
5. Nitric oxide-mediated mitochondrial damage in the brain: Mechanisms and implications for neurodegenerative diseases
6. Glia-dependent neurotoxicity and neuroprotection in mesencephalic cultures
7. Lipopolysaccharide intranigral injection induces inflammatory reaction and damage in nigrostriatal dopaminergic system
8. Neurons reduce glial responses to lipopolysaccharide (LPS) and prevent injury of microglial cells from over-activation by LPS
9. Glia: The not so innocent bystanders
10. The substantia nigra of the human brain. I. Nigrosomes and the nigral matrix, a compartmental organization based on calbindin D(28K) immunohistochemistry
11. The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease
12. Expression of inducible nitric oxide synthase causes delayed neurotoxicity in primary mixed neuronal-glial cortical cultures
13. Deficiency of inducible nitric oxide synthase protects against MPTP toxicity in vivo
14. Increased nitrotyrosine immunoreactivity in substantia nigra neurons in MPTP treated baboons is blocked by inhibition of neuronal nitric oxide synthase
15. Nitric oxide: Pathophysiological mechanisms
16. Inhibition of neuronal nitric oxide synthase prevents MPTP-induced parkinsonism in baboons
17. Nitric oxide, mitochondria and neurological disease
18. The single intranigral injection of LPS as a new model for studying the selective effects of inflammatory reactions on dopaminergic system
19. Selective potentiation of NMDA-induced neuronal injury following induction of astrocytic iNOS
20. Glial cells and inflammation in Parkinson's disease: A role in neurodegeneration?
21. Nitric oxide synthase and neuronal vulnerability in Parkinson's disease
22. FcEpsilonRII/CD23 is expressed in Parkinson's disease and induces, in vitro, production of nitric oxide and tumor necrosis factor-alpha in glial cells
23. Dopamine cell loss and expression of inducible nitric oxide synthase immunoreactivity following intranigral injection lipopolysaccharide
24. Oxidative mechanisms in nigral cell death in Parkinson's disease
25. Oxidative stress and the pathogenesis of Parkinson's disease
26. Understanding cell death in Parkinson's disease
27. Evidence for nitric oxide-mediated oxidative damage in chronic inflammation: Nitrotyrosine in serum and synovial fluid from rheumatoid patients
28. Regional differences in susceptibility to lipopolysaccharide-induced neurotoxicity in the rat brain: Role of microglia
29. Microglial and astrocytic involvement in a murine model of Parkinson's disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)
30. Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease
31. Naloxone protects rat dopaminergic neurons against inflammatory damage through inhibition of microglia activation and superoxide generation
32. Oxidative damage to proteins, lipids, and DNA in cortical brain regions from patients with dementia with Lewy bodies
33. Nitric oxide synthase inhibition and MPTP-induced toxicity in the common marmoset
34. + induced substantia nigra degeneration is attenuated in nNOS knockout mice
35. S-Methylthiocitrulline, a neuronal nitric oxide synthase inhibitor, protects against malonate and MPTP neurotoxicity
36. Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains
37. Expression of the histocompatibility glycoprotein HLA-DR in neurological disease
38. Altered glial function causes neuronal death and increased susceptibility to 1-methyl-4 phenylpyridium- and 6-hydroxydopamine-induced toxicity in astocytic ventral mesencephalic co-culture
39. Mitochondrial dysfunction in Parkinson's disease
40. Effects of systemic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine to mice on tyrosine hydroxylase, L-3,4-dihydroxyphenylalanine decarboxylase, dopamine beta-hydroxylase, and monoamine oxidase activities in the striatum and hypothalamus
41. Production of nitric oxide by glial cells: Regulation and potential roles in the CNS
42. Synthesis of nitric oxide in CNS glial cells
43. Nitric oxide as a product of mammalian cells
44. Selective upregulation of inducible nitric oxide synthase (iNOS) by lipopolysaccharide (LPS) and cytokines in microglia: In vitro and in vivo studies
45. Increased cerebrospinal fluid concentration of nitrite in Parkinson's disease
46. Inhibition of neuronal nitric oxide synthase by 7-nitroindazole protects against MPTP-induced neurotoxicity in mice
47. Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 1-methyl-4-phenylpyridinium ion on ATP levels of mouse brain synaptosomes
48. Increased microglial activation and protein nitration in white matter of the aging monkey
49. Isothioureas: Potent inhibitors of nitric oxide synthases with variable isoform selectivity
50. Histochemical mapping of nitric oxide synthase in the rat brain
51. Altered immune responses in mice lacking inducible nitric oxide synthase